Skip to main content

Advertisement

SpringerLink
Log in

Opioid Use in Urologic Practice

  • Neurogenic Bladder (C Powell, Section Editor)
  • Published:
Current Bladder Dysfunction Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

The opioid epidemic has become a major public health crisis over the last two decades. The opioid-related deaths and economic costs have increased dramatically since opioid analgesics started to be prescribed regularly to help control cancer- and non-cancer-related pain in the late twentieth century. As a result of the worsening opioid crisis, various guidelines and government regulations have recently been implemented to cope with this opioid problem as it affects all fields of medicine, urology included. Many conditions in urology involve chronic pain medication, including neurogenic bladder. This review seeks to summarize the growing problem of opioid use and prescribing practices nationwide.

Recent Findings

Specifically to urology, there is a growing body of literature that could aid urologists in creating good practices and guidelines to improve safety for patients requiring narcotic medications to increase awareness of new legal requirements and utilization of multimodal and alternative therapies post-operative, acute pain as well as chronic pain. The CDC has published 12 guidelines that have been used to frame state-specific chronic opioid prescribing guidelines and laws nationwide. Moreover, many states have enacted laws regulating the use of opioids and in some cases penalizing physicians for non-compliance. Specific to urology, studies have demonstrated unfilled opioid prescriptions after urologic procedures, considerable variability in the prescribing habits, and low rates of opioid dependency after prescription for acute post-operative pain.

Summary

Urologists and all physicians are increasingly under the microscope for opioid prescribing practices and need to understand current guidelines and literature.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Trescot AM, Helm S, Hansen H, Benyamin R, Glaser SE, Adlaka R, et al. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians’ (ASIPP) Guidelines. Pain Physician. 2008;11(2 Suppl):S5–S62.

    PubMed  Google Scholar 

  2. Jones MR, Viswanath O, Peck J, Kaye AD, Gill JS, Simopoulos TT. A brief history of the opioid epidemic and strategies for pain medicine. Pain Ther. 2018;7(1):13–21.

    Article  Google Scholar 

  3. Wolf JS. Opioid prescriptions for chronic pain. Opioid prescriptions for chronic pain. 2018. Available from: http://www.auanet.org/guidelines/opioid-prescriptions-for-chronic-pain. Accessed 26 Aug 2018.

  4. AUA position statement: opioid use. 2018. Available from: http://www.auanet.org/guidelines/opioid-use. Accessed 26 Aug 2018.

  5. Smith A, et al. Optimizing outcomes in urologic surgery: postoperative care. Urol Pract. 2020:7(1).

  6. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain--United States, 2016. JAMA. 2016;315(15):1624–45.

    Article  CAS  Google Scholar 

  7. Manchikanti L, Kaye AM, Knezevic NN, McAnally H, Slavin K, Trescot AM, et al. Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines. Pain Physician. 2017;20(2S):S3–S92.

    Article  Google Scholar 

  8. Kaye AD, Jones MR, Kaye AM, Ripoll JG, Galan V, Beakley BD, et al. Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse: part 1. Pain Physician. 2017;20(2S):S93–S109.

    Article  Google Scholar 

  9. Hacker K, et al. MP80-11 post-operative opioid prescribing in urology: are we contributing to the national crisis? J Urol. 2018;199(4):e1093.

    Google Scholar 

  10. Howard R, et al. Spillover effect of evidence-based opioid prescribing after surgery. J Am Coll Surg. 2018.

  11. Fujii MH, Hodges AC, Russell RL, Roensch K, Beynnon B, Ahern TP, et al. Post-discharge opioid prescribing and use after common surgical procedure. J Am Coll Surg. 2018;226(6):1004–12.

    Article  Google Scholar 

  12. Starks C, et al. Reduction in opioid prescribing using a postoperative pain management protocol following scrotal and subinguinal surgery. Urol Pract. 2018;5:217–22.

    Article  Google Scholar 

  13. Borza T, et al. Variation in national opioid prescribing patterns following outpatient nephrolithiasis procedures. In: American Urologic Association. Boston: AUA , Inc.; 2017. p. MP75–04.

    Google Scholar 

  14. Shah AS, Blackwell RH, Kuo PC, Gupta GN. Rates and risk factors for opioid dependence and overdose after urological surgery. J Urol. 2017;198(5):1130–6.

    Article  Google Scholar 

  15. Brummett CM, et al. New persistent opioid use after minor and major surgical procedures in US adults. JAMA Surg. 2017;152(6):e170504.

    Article  Google Scholar 

  16. Shah A, Hayes CJ, Martin BC. Characteristics of initial prescription episodes and likelihood of long-term opioid use - United States, 2006-2015. MMWR Morb Mortal Wkly Rep. 2017;66(10):265–9.

    Article  Google Scholar 

  17. Guideline for prescribing opioids for chronic pain. 2018. Available from: www.cdc.gov/drugoverdose/prescribing/guideline.html. Accessed 26 Aug 2018.

  18. Cantrill SV, Brown MD, Carlisle RJ, Delaney KA, Hays DP, Nelson LS, et al. Clinical policy: critical issues in the prescribing of opioids for adult patients in the emergency department. Ann Emerg Med. 2012;60(4):499–525.

    Article  Google Scholar 

  19. Auriacombe M, et al. French field experience with buprenorphine. Am J Addict. 2004;13(Suppl 1):S17–28.

    Article  Google Scholar 

  20. Thalmayer AG, et al. The Mental Health Parity and Addiction Equity Act Evaluation Study: impact on nonquantitative treatment limits for specialty behavioral health care. Health Serv Res. 2018.

  21. Thalmayer AG, Friedman SA, Azocar F, Harwood JM, Ettner SL. The Mental Health Parity and Addiction Equity Act (MHPAEA) evaluation study: impact on quantitative treatment limits. Psychiatr Serv. 2017;68(5):435–42.

    Article  Google Scholar 

  22. Skaer TL, Nwude AC. Opioid prescribing laws and emergency department guidelines for chronic non-cancer pain in Washington State. Pain Pract. 2016;16(5):642–7.

    Article  Google Scholar 

  23. Sajid A, Whiteman A, Bell RL, Greene MS, Engleman EA, Chambers RA. Prescription drug monitoring program data tracking of opioid addiction treatment outcomes in integrated dual diagnosis care involving injectable naltrexone. Am J Addict. 2016;25(7):557–64.

    Article  Google Scholar 

  24. Ziegelmann M, et al. PD28-07 evidence-based opioid prescribing guidelines for the postoperative urologic surgery patient at discharge. J Urol. 2018;199(4):e565.

    Google Scholar 

  25. Portis, A. et al, MP02-18 non-narcotic emergency management of renal colic improves length of stay and discharge rate. J Urol. 2018;199(Issue 4):e19.

  26. Manchikanti L, Abdi S, Atluri S, Balog CC, Benyamin RM, Boswell MV, et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part 2--guidance. Pain Physician. 2012;15(3 Suppl):S67–116.

    PubMed  Google Scholar 

  27. Manchikanti L, Abdi S, Atluri S, Balog CC, Benyamin RM, Boswell MV, et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part I--evidence assessment. Pain Physician. 2012;15(3 Suppl):S1–65.

    PubMed  Google Scholar 

  28. Cichowski SB, et al. A 10-yr analysis of chronic pelvic pain and chronic opioid therapy in the women veteran population. Mil Med. 2018.

  29. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain - United States, 2016. MMWR Recomm Rep. 2016;65(1):1–49.

    Article  Google Scholar 

  30. Hanno PM, et al. AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2011;185(6):2162–70.

    Article  Google Scholar 

  31. What is the U.S. opioid epidemic? Available from: https://www.hhs.gov/opioids/about-the-epidemic/index.html. Accessed 26 Aug 2018.

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Indiana University School of Medicine, 535 Barnhill Dr. Suite 420, Indianapolis, IN, 46202, USA

    CR Powell & Isamu Tachibana

Authors
  1. CR Powell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Isamu Tachibana
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to CR Powell.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Neurogenic Bladder

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Powell, C., Tachibana, I. Opioid Use in Urologic Practice. Curr Bladder Dysfunct Rep 15, 53–59 (2020). https://doi.org/10.1007/s11884-020-00576-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11884-020-00576-2

Keywords

Search

Navigation